Abstracts tagged "fibromyalgia"

Abstract Number: 1991 • 2017 ACR/ARHP Annual Meeting
Fibromyalgia in Russian Refugees: Translation and Validation of the Revised Symptom Impact Questionnaire
Kim Jones¹, Robert M. Bennett¹, Ronald Friend² and Neema Mohammad Nader², ¹Schools of Nursing and Medicine, Oregon Health & Science University, Portland, OR, ²School of Nursing, Oregon Health & Science University, Portland, OR
Background/Purpose: The Revised Symptom Impact Questionnaire (SIQR) is an updated version of the Revised Fibromyalgia Impact Questionnaire (FIQR) that can be used in both fibromyalgia…
Abstract Number: 160 • 2017 ACR/ARHP Annual Meeting
Fibromyalgia Screening Form in the Diagnosis of Concomitant Fibromyalgia
Robert S. Katz¹ and Jessica L. Polyak², ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates S.C., Chicago, IL
Background/Purpose: We have found that patients with a variety of rheumatic diseases who have concomitant fibromyalgia more frequently fail therapies for the underlying inflammatory rheumatic…
Abstract Number: 2115 • 2017 ACR/ARHP Annual Meeting
Mast Cell Activation Features in Ehlers-Danlos/Joint Hypermobility Patients: A Retrospective Analysis in Light of an Emerging Disease Cluster
Dave Lee¹ and Eric Mueller², ¹Arthritis Northwest, PLLC, Spokane, WA, ²Discus Analytics LLC., Spokane, WA
Background/Purpose: Mast cells are immune cells often residing in connective tissue, best known for their role in allergic and anaphylactic responses1. Mast cell activation syndrome…
Abstract Number: 843 • 2017 ACR/ARHP Annual Meeting
The Role of Personality in Patients with Fibromyalgia
Andrew Seto¹, Teresa Wu¹, Lori Lyn Price^2,3,4,5, Xingyi Han⁶, William F. Harvey¹ and Chenchen Wang⁷, ¹Tufts Medical Center, Boston, MA, ²Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ³Clinical Care Research, Tufts Medical Center, Boston, MA, ⁴Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ⁵Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, ⁶Public Health and Community Medicine, Tufts University, Boston, MA, ⁷Rheumatology, Tufts Medical Center, Boston, MA
Background/Purpose: Previous studies investigating the potential associations between personality and clinical symptoms in fibromyalgia (FM) patients have found mixed results. The purpose of this study…
Abstract Number: 2247 • 2017 ACR/ARHP Annual Meeting
Secondary Fibromyalgia Is Not Associated with Higher Likelihood of Patient-Physician Discordance in Global Assessment in Patients with Osteoarthritis and Rheumatoid Arthritis
Isabel Castrejón, Shakeel M. Jamal and Najia Shakoor, Division of Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Pain is the strongest driver of patient-physician discordance in global assessment in patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Having secondary fibromyalgia (FM),…
Abstract Number: 1101 • 2017 ACR/ARHP Annual Meeting
Systematic Physician Assessment Beyond Inflammation in Routine Rheumatology Care Using Visual Analog Scale Scores for Inflammation, Damage, and Distress to Document Patient Status and Support Clinical Decisions: Analysis of Inter-Rater Reliability
Shakeel M. Jamal¹, Theodore Pincus², Isabel Castrejón², Jacquelin R. Chua¹, Aman Kugasia¹, Juan Schmukler¹, Stacy Weinberg¹ and Joel A. Block³, ¹Division of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³Rush University Medical Center, Chicago, IL
Background/Purpose: A physician global estimate of patient status (DOCGL) on a 0-10 visual analog scales (VAS) is as effective as any rheumatoid arthritis (RA) Core…
Abstract Number: 2992 • 2017 ACR/ARHP Annual Meeting
Curbing the Opioid Epidemic: Predictors of Opioid Use in Juvenile Fibromyalgia Syndrome
Sabrina Gmuca¹, Rui Xiao², Andrea M. Knight³, David D. Sherry¹, Pamela F. Weiss⁴ and Jeffrey S. Gerber⁵, ¹Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ²Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, ³Division of Rheumatology, Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, ⁴Division of Rheumatology, Center for Pediatric Clincial Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, ⁵Children's Hospital of Philadelphia, Philadelphia, PA
Background/Purpose: Despite the lack of evidence to support the use of opioids in the treatment of adult fibromyalgia syndrome, approximately 30% of patients receive an…
Abstract Number: 1247 • 2017 ACR/ARHP Annual Meeting
Coexisting Fibromyalgia in Patients with Rheumatoid Arthritis Worsens Scores for Pain, Physical Function and Depression
Dylan Ruebeck¹, Judith Baumhauer² and Allen P. Anandarajah³, ¹Internal Medicine, University of Rochester Medical Center, Rochester, NY, ²Orthopedics, University of Rochester Medical Center, rochester, NY, ³Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY
Background/Purpose: Quality of life (QOL) measures as assessed by Patient Reported Outcome Measurement Information System (PROMIS) can contribute essential information about the status of or…
Abstract Number: 1359 • 2017 ACR/ARHP Annual Meeting
M-DAS28, M-SDAI and M-CDAI Performance in a Cohort of RA Patients with and without Concomitant Fibromyalgia
Julia Sosa¹, Silvana Karina Pérez¹, Maria Julia Santa Cruz¹, María Alejandra Medina¹, Silvia Beatriz Papasidero¹, Diana Klajn², Jose Angel Caracciolo¹, María de los Angeles Correa³, Roger Rolón⁴, Gustavo Citera⁴, Maria Constanza Bertolaccini⁵, LL Gonzalez⁶, L Vargas⁷ and Oscar Rillo⁷, ¹Rheumatology Department, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, ²Research Committee, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, ³Section Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Buenos Aires, Argentina, ⁴Rheumatology Department, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁵Rheumatology, Hospital Angel Cruz Padilla, Tucumán, Argentina, ⁶Hospital Angel Cruz Padilla, Tucumán, Argentina, ⁷Rheumatology Department, Hospital General de Agudos Dr. Ignacio Pirovano, Buenos Aires, Argentina
Background/Purpose: Fibromyalgia has been reported in approximately 20% of Rheumatoid Arthritis (RA) patients. Several studies have shown that the presence of Fibromyalgia (FM) is associated…
Abstract Number: 1653 • 2017 ACR/ARHP Annual Meeting
Factors Influencing on Health-Related Quality of Life in Female Systemic Lupus Erythematosus Patients with Fibromyalgia
Kyung Min Ko¹, Jun-Ki Min² and Su-Jin Moon³, ¹Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), ²Bucheon St. Mary's Hospital, Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Bucheon, Korea, Republic of (South), ³Bucheon St. Mary's Hospital, Division of rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Bucheon, Korea, Republic of (South)
Background/Purpose: Health-related quality of life (HRQoL) among systemic lupus erythematosus (SLE) patients is reduced, and fibromyalgia contribute to the decreased HRQoL. The objective of the…
Abstract Number: 1868 • 2017 ACR/ARHP Annual Meeting
Association between Brain-Derived Neurotrophic Factor Gene Polymorphisms and Fibromyalgia in a Korean Population: A Multi-Center Study
Ji-Hyoun Kang¹, Kyung-Eun Lee², Dong-Jin Park¹, Seong-Ho Kim³, Seong-Su Nah⁴, Ji Hyun Lee⁵, Seong-Kyu Kim⁶, Yeon-Ah Lee⁷, Seung-Jae Hong⁸, Hyun-Sook Kim⁹, Hye-Soon Lee¹⁰, Hyoun-Ah Kim¹¹, Chung-Il Joung¹², Sang-Hyon Kim¹³ and Shin-Seok Lee¹, ¹Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), ²Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), ³Inje University Haeundae Paik Hospital, Busan, Korea, Republic of (South), ⁴Soonchunhyang University, College of Medicine, Cheonan, Korea, Republic of (South), ⁵Maryknoll Medical Center, Busan, Korea, Republic of (South), ⁶Rheumatology, Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South), ⁷Rheumatology, Kyung Hee University Hospital, Seoul, Korea, Republic of (South), ⁸Dept. of Rheumatology, #1 Hoeg, KyungHee University Medical Center, SEOUL, Korea, Republic of (South), ⁹Soonchenhyang university school of medicine, Seoul, Korea, Republic of (South), ¹⁰Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of (South), ¹¹Ajou University Hospital, Suwon, Korea, Republic of (South), ¹²Konyang University Medical School, Daejeon, Korea, Republic of (South), ¹³Division of Rheumatology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea, Daegu, Korea, Republic of (South)
Background/Purpose: Several lines of evidence suggest that brain-derived neurotrophic factor (BDNF) is involved in the pathophysiology of fibromyalgia (FM) and studies have found that FM…
Abstract Number: 1869 • 2017 ACR/ARHP Annual Meeting
Effects of Add-on Transcranial Direct Current Stimulation on Pain in Korean Patients with Fibromyalgia
Ji-Hyoun Kang¹, Kyung-Eun Lee², Dong-Jin Park¹ and Shin-Seok Lee¹, ¹Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), ²Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South)
Background/Purpose: Despite promising preliminary results of transcranial direct current stimulation (tDCS) treatment in patients with fibromyalgia (FM), several issues need to be addressed, including its…
Abstract Number: 1872 • 2017 ACR/ARHP Annual Meeting
The Effect of EEG-Amygdala-Related-Neurofeedback on REM Latency in Patients with Fibromyalgia
Noam Goldwway¹, Haggai Sharon¹, Eti Ben Simon¹, Libat Weizman¹, Ayam Greental¹, Omer Lubin¹, Marc Cavazza², Fred Charles³, Talma Hendler¹ and Jacob N. Ablin⁴, ¹Functional Brain Center, Wohl Institute for Advanced Imaging, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel, ²School of Computing, Teesside University, United Kingdom, Middlesbrough, United Kingdom, ³Department of Creative Technology, Bournemouth University, Bournemouth, United Kingdom, ⁴Rheumatology, Rheumatology Institute, Tel Aviv, Tel Aviv, Israel
Background/Purpose: Fibromyalgia syndrome (FMS) is a condition characterized by widespread pain, sleep disturbance and chronic fatigue, and mood disorder .FMS was suggested to represent a…
Abstract Number: 1873 • 2017 ACR/ARHP Annual Meeting
Evaluating Pain Related Disability in Fibromyalgia: A Comparison of the Fibromyalgia Impact Questionnaire and the Polysymptomatic Distress Scale
Nilamba Jhala¹, Yaseen Kinanah², Sahar Kaouk³, Deb Bork⁴, Sara Davin⁵, Sarah Rispinto⁵, William Wilke⁴ and Carmen E. Gota⁴, ¹Internal Medicine, Cleveland Clinic, Cleveland, OH, ²Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, ³John Carroll University, University Heights, OH, ⁴Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, ⁵Neurologic Institute, Cleveland Clinic, Cleveland, OH
Background/Purpose: Both the fibromyalgia impact questionnaire (FIQ) and the polysymptomatic distress scale (PSD) have been proposed as measures of FM impact and severity. It is…
Abstract Number: 1973 • 2017 ACR/ARHP Annual Meeting
Fibromyalgia in Real Life a National French Web-Based Survey in 4516 Patients
Francoise Laroche¹, julien Guerin², deborah Azoulay³, joel Coste⁴ and serge Perrot³, ¹Pain and Palliative care, APHP Hospital, Paris, France, ²CETD, APHP Hospital, Paris, France, ³CETD, Paris, France, ⁴Biostatistics in university Hospital, Paris, France
Background/Purpose: Fibromyalgia (FM) is the most frequent widespread chronic pain disorder (1,6% of the French population) (1). The medical and socioeconomic burden is high and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].